切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2022, Vol. 11 ›› Issue (03) : 258 -262. doi: 10.3877/cma.j.issn.2095-3232.2022.03.009

临床研究

再次肝切除与腹腔镜微波消融治疗复发性小肝癌临床疗效比较
谢静1, 毛先海2, 杨建辉2, 段小辉2, 田朕安1, 张雄1, 高绪照1,()   
  1. 1. 427000 湖南省张家界市人民医院肝胆外科
    2. 410005 长沙,湖南省人民医院肝胆外科
  • 收稿日期:2022-02-14 出版日期:2022-06-10
  • 通信作者: 高绪照
  • 基金资助:
    湖南省自然科学基金(2018JJ3294,2019JJ80007); 湖南省教育厅科学研究重点项目(16A127)

Comparison of clinical efficacy between re-hepatectomy and laparoscopic microwave ablation for recurrent small hepatocellular carcinoma

Jing Xie1, Xianhai Mao2, Jianhui Yang2, Xiaohui Duan2, Zhen'an Tian1, Xiong Zhang1, Xuzhao Gao1,()   

  1. 1. Department of Hepatobiliary Surgery, Zhangjiajie City People's Hospital, Zhangjiajie 427000, China
    2. Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, Changsha 410005, China
  • Received:2022-02-14 Published:2022-06-10
  • Corresponding author: Xuzhao Gao
引用本文:

谢静, 毛先海, 杨建辉, 段小辉, 田朕安, 张雄, 高绪照. 再次肝切除与腹腔镜微波消融治疗复发性小肝癌临床疗效比较[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 258-262.

Jing Xie, Xianhai Mao, Jianhui Yang, Xiaohui Duan, Zhen'an Tian, Xiong Zhang, Xuzhao Gao. Comparison of clinical efficacy between re-hepatectomy and laparoscopic microwave ablation for recurrent small hepatocellular carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(03): 258-262.

目的

比较再次肝切除(RH)与腹腔镜微波消融(LMWA)治疗复发性小肝癌的临床疗效。

方法

回顾性分析2016年1月至2018年1月湖南省人民医院诊治的71例复发性肝癌患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男44例,女27例;年龄34~76岁,中位年龄51岁。根据治疗方式将患者分为RH组(40例)和LMWA组(31例)。两组手术时间、术后住院时间、住院费用比较采用t检验;术中出血量比较采用Mann-Whitney U检验;术后并发症发生率比较采用χ2检验。生存分析采用Kaplan-Meier法和Log-rank检验。

结果

LMWA组术中出血量为10(10)ml,明显少于RH组的200(100)ml(Z=-7.278,P<0.05);手术时间、术后住院时间、住院费用分别为(37±11)min、(4.7±1.1)d、(1.6±0.4)万元,亦明显少于RH组的(141±37)min、(9.6±1.9) d、(3.4±2.1)万元(t=-235.125,-161.889,-23.359;P<0.05)。LMWA组术后并发症发生率为29%(9/31),明显低于RH组的73%(29/40) (χ2 =1.309,P<0.05)。RH组和LMWA组1、2、3年无瘤生存率分别为70.0%、52.5%、30.0%和67.7%、48.4%、29.0%,差异无统计学意义(χ2=0.042,P>0.05)。

结论

对复发性小肝癌的治疗,RH和LMWA两种治疗方法疗效无明显差异,但LMWA在操作可重复性、经济性、微创性及安全性等方面具有明显优势。

Objective

To compare the clinical efficacy between re-hepatectomy (RH) and laparoscopic microwave ablation (LMWA) in the treatment of recurrent small hepatocellular carcinoma (HCC).

Methods

Clinical data of 71 patients with recurrent small HCC treated in Hunan Provincial People's Hospital from January 2016 to January 2018 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 44 patients were male and27 female, aged from 34 to 76 years, with a median age of 51 years. All patients were divided into the RH (n=40) and LMWA groups (n=31) according to different treatments. The operation time, length of postoperative hospital stay and hospitalization expense between two groups were compared by t test. Intraoperative blood loss was compared by Mann-Whitney U test. The incidence of postoperative complications was compared by Chi-square test. Survival analysis was performed by Kaplan-Meier method and Log-rank test.

Results

Intraoperative blood loss in the LMWA group was 10(10) ml, significantly less than 200(100) mlin the RH group (Z=-7.278, P<0.05). In the LMWA group, the operation time, length of postoperative hospital stay and hospitalization expense were (37±11) min, (4.7±1.1) d and (1.6±0.4)×104 Yuan, significantly less compared with (141±37) min, (9.6±1.9) d and (3.4±2.1)×104 Yuan in the RH group(t=-235.125, -161.889, -23.359; P<0.05). In the LMWA group, the incidence of postoperative complications was 29%(9/31), significantly lower than 73%(29/40) in the RH group (χ2=1.309, P<0.05). The 1-, 2- and 3-year tumor-free survival rates in the RH and LMWA groups were 70.0%, 52.5%, 30.0%, and 67.7%, 48.4%, 29.0%, with no significant differences (χ2=0.042, P>0.05).

Conclusions

RH and LMWA yield similar clinical efficacy in the treatment of recurrent small HCC, whereas LMWA has significant advantages over RH in repeatability, expense, minimal invasiveness and safety, etc.

表1 LMWA组和RH组复发性肝癌患者一般情况比较
表2 LMWA组和RH组复发性肝癌患者围手术期情况比较
表3 LMWA组和RH组复发性肝癌患者术后并发症发生情况(例)
图1 LMWA组和RH组复发性肝癌患者Kaplan-Meier无瘤生存曲线注:LMWA为腹腔镜微波消融,RH为再次肝切除
图2 LMWA组和RH组复发性肝癌患者Kaplan-Meier总体生存曲线注:LMWA为腹腔镜微波消融,RH为再次肝切除
[1]
左婷婷, 郑荣寿, 曾红梅, 等. 中国肝癌发病状况与趋势分析[J]. 中华肿瘤杂志, 2015, 37(9):691-696.
[2]
应倩, 汪媛. 肝癌流行现况和趋势分析[J]. 中国肿瘤, 2020, 29(3):185-191.
[3]
Lacaze L, Scotté M. Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma[J]. World J Hepatol, 2015, 7(13):1755-1760.
[4]
黄建钊, 刘江伟, 孙倩, 等. 射频消融与手术切除治疗肝癌的疗效比较[J]. 广东医学, 2012, 33(13):1991-1993.
[5]
Yamashita Y, Tsuijita E, Takeishi K, et al. Trends in surgical results of hepatic resection for hepatocellular carcinoma: 1,000 consecutive cases over 20 years in a single institution[J]. Am J Surg, 2014, 207(6):890-896.
[6]
Nakayama H, Takayama T. Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma[J]. World J Hepatol, 2015, 7(2):261-269.
[7]
中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版)[J]. 中华消化外科杂志, 2017, 16(7):635-647.
[8]
Toshiyuki I, Hideki N, Hironobu A, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma[J]. Surgery, 2007, 141(5):589-597.
[9]
Xia Y, Li J, Liu G, et al. Long-term effects of repeat hepatectomy vs percutaneous radiofrequency ablation among patients with recurrent hepatocellular carcinoma: a randomized clinical trial[J]. JAMA Oncol, 2020, 6(2):255-263.
[10]
Chan DL, Morris DL, Chua TC. Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma-a systematic review[J]. Surg Oncol, 2013, 22(2):e22-30.
[11]
Zhou Y, Sui C, Li B, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review[J]. World J Surg Oncol, 2010(8):55.
[12]
Erridge S, Pucher PH, Markar SR, et al. Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma[J]. Br J Surg, 2017, 104(11):1433-1442.
[13]
Makino Y, Yamanoi A, Kimoto T, et al. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma[J]. Am J Gastroenterol, 2000, 95(5): 1294-1300.
[14]
Xu RH, Gao W, Wang C, et al. Systematic evaluation of percutaneous radiofrequency ablation versus percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: a meta-analysis[J]. Eur J Med Res, 2014, 19(1):39.
[15]
杨藩, 张二雷, 童兵, 等. 对比经皮微波消融与手术切除治疗合并肝硬化的单发小肝癌疗效分析[J]. 肝胆外科杂志, 2015, 23(6): 421-425.
[16]
周传力, 张珍, 徐亚吉, 等. 经皮微波消融与手术切除治疗原发性小肝癌疗效Meta分析[J]. 四川生理科学杂志, 2019, 41(2): 103-107.
[17]
肖梅. 腹腔镜微波消融治疗肝癌的策略分析[J]. 中国医刊, 2015, 50(2):7-9.
[18]
Kang TWKim JMRhim H,et al. Small hepatocellular carcinoma: radiofrequency ablation versus nonanatomic resection--propensity score analyses of long-term outcomes[J]. Radiology2015, 275(3): 908-919.
[19]
Fang Y, Chen W, Liang X, et al. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma[J]. Gastroenterol Hepatol, 201429(1):193-200.
[20]
蒋恒, 万圣云, 侯辉, 等. 肝癌复发后再次肝切除与射频消融疗效的Meta分析[J]. 中华普通外科杂志, 2015, 30(2):146-149.
[21]
冯国英, 李佳明, 杨旭, 等. 重复肝切除术与射频消融术治疗复发性肝癌疗效对比的Meta分析[J]. 重庆医学, 2021, 50(10): 1753-1759.
[22]
张婷婷, 李开艳, 张伟, 等. 经皮微波消融治疗术后复发性肝癌的长期生存影响因素分析[J]. 中华超声影像学杂志, 2013, 22(11):957-961.
[23]
Sparchez Z, Mocan T, Radu P, et al. Prognostic factors after percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma. impact of incomplete ablation on recurrence and overall survival rates[J]. J Gastrointestin Liver Dis, 2018, 27(4):399-407.
[24]
冯含昕, 赵阳, 徐锋, 等. 微波消融技术在肝癌治疗的应用现状和展望[J/CD]. 中华普通外科学文献(电子版), 2020, 14(6):458-462.
[25]
史瑶平, 翟博. 肝癌局部治疗——消融或切除?[J].临床肝胆病杂志, 2021, 37(3):506-509.
[1] 李凯, 陈淋, 向涵, 苏怀东, 张伟. 一种U型记忆合金线在经脐单孔腹腔镜阑尾切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 15-15.
[2] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[3] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[4] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[5] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[6] 李晓玉, 江庆, 汤海琴, 罗静枝. 围手术期综合管理对胆总管结石并急性胆管炎患者ERCP +LC术后心肌损伤的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 57-60.
[7] 甄子铂, 刘金虎. 基于列线图模型探究静脉全身麻醉腹腔镜胆囊切除术患者术后肠道功能紊乱的影响因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 61-65.
[8] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[9] 曹迪, 张玉茹. 经腹腔镜生物补片修补直肠癌根治术后盆底疝1例[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 115-116.
[10] 易明超, 汪鑫, 向涵, 苏怀东, 张伟. 一种T型记忆金属线在经脐单孔腹腔镜胆囊切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 599-599.
[11] 唐健雄, 李绍杰. 不断推进中国腹腔镜疝手术规范化[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 591-594.
[12] 田文, 杨晓冬. 腹腔镜腹股沟疝修补术式选择及注意事项[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 595-597.
[13] 李涛, 陈纲, 李世拥. 腹腔镜下右侧腹股沟斜疝修补术(TAPP)[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 598-598.
[14] 易明超, 汪鑫, 向涵, 苏怀东, 张伟. 一种T型记忆金属线在经脐单孔腹腔镜胆囊切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 599-599.
[15] 李莹倩, 李华山. 基于真实世界的完全性直肠脱垂治疗方式评价[J]. 中华临床医师杂志(电子版), 2023, 17(06): 700-705.
阅读次数
全文


摘要